Liver Health And Metabolism: Why The Liver Controls More Than You Think

The liver is the largest internal organ and arguably the most metabolically consequential. It governs glucose production and storage, lipid handling, protein synthesis, hormone clearance and detoxification. Subtle changes in hepatic function ripple across every other metabolic system in the body.

Between meals and overnight, the liver releases glucose into circulation to maintain stable blood sugar. In insulin-resistant individuals, this output becomes inappropriately elevated, contributing substantially to fasting hyperglycemia. Restoring normal hepatic insulin sensitivity is therefore one of the highest-leverage metabolic interventions available.

Non-alcoholic fatty liver disease (NAFLD) — recently renamed metabolic-associated fatty liver disease (MAFLD) — affects approximately 25% of adults globally. It is closely linked with insulin resistance, abdominal adiposity and metabolic syndrome, and progresses in some individuals to non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis.

Hepatic fat accumulation is both a consequence and a driver of broader metabolic dysfunction. Excess liver fat impairs insulin signalling and contributes to dyslipidemia, hypertension and inflammatory markers across the body.

Multiple randomised trials have examined berberine in adults with NAFLD. Reported outcomes include reductions in hepatic fat content on imaging, improvements in liver enzymes, and corresponding improvements in glycemic and lipid markers. Mechanistically, berberine suppresses hepatic lipogenesis through SREBP-1c downregulation and improves hepatic insulin sensitivity through AMPK activation.

Berberine's hepatic effects appear most pronounced in adults with established metabolic dysfunction. Its safety profile in liver-impaired patients should be discussed with a qualified clinician.